| 05/04/2026 11:49 AM | Hensley Mark Earl (2065816) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 11:35 AM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 10:56 AM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 10:30 AM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/30/2026 1:09 PM | Heron Therapeutics (818033) Filer | Form DEF 14A | |
| 04/30/2026 1:09 PM | Heron Therapeutics (818033) Filer | Form DEFA14A | |
| 04/30/2026 1:10 PM | Heron Therapeutics (818033) Filer | Form ARS | |
| 04/21/2026 10:15 AM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 8:41 AM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 8:13 AM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 4:13 PM | Heron Therapeutics (818033) Filer | Form PRE 14A | |
Get the Latest News and Ratings for HRTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Heron Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/06/2026 6:06 PM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/06/2026 7:30 AM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/27/2026 8:30 AM | Heron Therapeutics (818033) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 02/26/2026 7:06 AM | Heron Therapeutics (818033) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/26/2026 7:00 AM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/17/2026 1:40 PM | Clearline Capital LP (1600136) Filed by Heron Therapeutics (818033) Subject | Form SCHEDULE 13G/A | |
| 02/03/2026 9:00 AM | Hensley Mark Earl (2065816) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 9:00 AM | Dissanaike Sharmila (1885069) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 9:00 AM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 9:00 AM | Cusack Thomas (2094824) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 9:00 AM | Heron Therapeutics (818033) Issuer Johnson Craig A (1370348) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 9:00 AM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 9:00 AM | Heron Therapeutics (818033) Issuer Kaseta Michael (1724346) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 9:00 AM | Christian Waage (1553179) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 9:00 AM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 8:15 AM | Heron Therapeutics (818033) Issuer Morgan Adam (1964335) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 7:30 AM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 7:30 AM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 7:30 AM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 2:00 PM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 1:39 PM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 1:49 PM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/09/2026 12:08 PM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/26/2025 9:15 AM | Clearline Capital LP (1600136) Filed by Heron Therapeutics (818033) Subject | Form SCHEDULE 13G | |
| 11/12/2025 8:20 AM | Cusack Thomas (2094824) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/07/2025 8:30 AM | Cusack Thomas (2094824) Reporting Heron Therapeutics (818033) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 11/04/2025 11:33 AM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/04/2025 11:35 AM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/04/2025 11:31 AM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/04/2025 7:00 AM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
| 11/04/2025 7:00 AM | Heron Therapeutics (818033) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/21/2025 10:56 AM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/21/2025 10:42 AM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/21/2025 10:23 AM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/17/2025 5:00 PM | Heron Therapeutics (818033) Issuer Rosen David Efraim (1898677) Reporting Rubric Capital Management LP (1687509) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/17/2025 5:02 PM | Heron Therapeutics (818033) Subject Rubric Capital Management LP (1687509) Filed by | Form SCHEDULE 13D/A | |
| 10/15/2025 3:09 PM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/19/2025 3:05 PM | Heron Therapeutics (818033) Filer | Form DEF 14A | |
| 09/16/2025 11:15 PM | Heron Therapeutics (818033) Filer | Form EFFECT | |
| 09/16/2025 11:15 PM | Heron Therapeutics (818033) Filer | Form EFFECT | |
| 09/09/2025 4:07 PM | Heron Therapeutics (818033) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 09/09/2025 4:12 PM | Heron Therapeutics (818033) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 09/09/2025 4:03 PM | Heron Therapeutics (818033) Filer | Form PRE 14A | |
| 08/15/2025 6:45 AM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/15/2025 6:53 AM | Heron Therapeutics (818033) Filer | Form 8-A12B | |
| 08/12/2025 5:00 PM | Heron Therapeutics (818033) Issuer Rosen David Efraim (1898677) Reporting Rubric Capital Management LP (1687509) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/12/2025 5:00 PM | Heron Therapeutics (818033) Subject Rubric Capital Management LP (1687509) Filed by | Form SCHEDULE 13D/A | |
| 08/12/2025 3:45 PM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/12/2025 3:35 PM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/08/2025 6:45 AM | Heron Therapeutics (818033) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/08/2025 6:45 AM | Heron Therapeutics (818033) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/04/2025 4:21 PM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/04/2025 4:27 PM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/04/2025 4:29 PM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/22/2025 10:55 AM | Collard Craig A (1363558) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/22/2025 11:23 AM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/22/2025 11:43 AM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2025 4:53 PM | Duarte Ira (1488864) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2025 6:54 PM | Forbes William P (1314760) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2025 11:20 AM | Hensley Mark Earl (2065816) Reporting Heron Therapeutics (818033) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |